Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme
J Thromb Haemost
.
2021 Sep;19(9):2363-2364.
doi: 10.1111/jth.15433.
Epub 2021 Jul 9.
Authors
Fredrik Kahn
1
,
Oonagh Shannon
1
,
Lars Björck
1
Affiliation
1
Clinical Sciences, Lund University, Lund, Sweden.
PMID:
34165239
PMCID:
PMC8420602
DOI:
10.1111/jth.15433
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines*
COVID-19*
Humans
SARS-CoV-2
Streptococcus pyogenes
Vaccination / adverse effects
Substances
COVID-19 Vaccines